Lilly psoriasis drug fares well in late-stage test

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

The Indianapolis-based company announced initial results from the research on Thursday and said it plans to submit the drug, ixekizumab, to regulators in the first half of next year. The drugmaker has been pushing to develop new treatments to replace revenue lost due to a wave of patent expirations that have hit top-selling drugs like the antidepressant Cymbalta.

In the ixekizumab research, between 31% and 41% of the patients taking its drug achieved clear skin, according to the drugmaker. Overall, those on the drug achieved better levels of skin clearance than patients taking a fake treatment or etanercept, which goes by the brand name Enbrel and is sold by Amgen Inc. and Pfizer Inc.

Psoriasis is a chronic disease that occurs when a person's immune system speeds up the growth cycle of skin cells. The most common form, plaque psoriasis, creates raised, red patches on the skin.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Skin care tips for psoriasis patients

Aug 25, 2013

(HealthDay)—Sun protection is among the skin care habits that can help people with the chronic skin condition psoriasis reduce some of the discomfort they may experience, such as skin itching, cracking ...

AstraZeneca says DOJ closes probe into drug trial

Aug 19, 2014

British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action.

Eli Lilly 2013 profit forecast tops expectations

Jan 04, 2013

(AP)—Eli Lilly and Co. said Friday its 2013 earnings will grow more than Wall Street expects, even though the drugmaker will lose U.S. patent protection for two more key products this year.

Recommended for you

Seniors successfully withdraw from meds

8 hours ago

Elderly people have proved receptive to being de-prescribed medications, as part of a trial aimed at assessing the feasibility of withdrawal of medications among older people.

Flu vaccine for expectant moms a top priority

Sep 18, 2014

Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness.

Experts want restrictions on testosterone drug use (Update)

Sep 17, 2014

Federal health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans ...

User comments